Status:
COMPLETED
Non-Invasive Lung Water Monitoring in Pulmonary Hypertension
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18-85 years
Brief Summary
The investigators conducted a prospective, convenience-sampled observational pilot study, enrolling adult patients with pulmonary hypertension who were either outpatients or inpatients in the cardiolo...
Detailed Description
The investigators conducted a prospective, convenience-sampled observational pilot study, enrolling adult patients with pulmonary hypertension who were either outpatients or inpatients in the cardiolo...
Eligibility Criteria
Inclusion
- Age ≥18 and ≤85 years, with no gender restriction;
- Hemodynamic confirmation of PH via right heart catheterization (RHC) (mean pulmonary arterial pressure \[mPAP\] \> 20 mmHg).
Exclusion
- Thoracic deformities or injuries precluding proper device fit (e.g., severe scoliosis, flail chest);
- Inability to use the ReDS™ Pro non-invasive lung fluid monitor due to physical characteristics (height \<155 cm or \>190 cm; body mass index \[BMI\] \<22 kg/m² or \>39 kg/m²);
- Prior implantation of a left ventricular assist device or cardiac transplantation;
- Congenital cardiac anomalies or intrathoracic masses affecting right lung anatomy;
- Hemodynamic profiles inconsistent with PH.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT06942871
Start Date
April 1 2024
End Date
March 31 2025
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
180 Fenglin Road
Shanghai, China, 200032